ACTUATE THERAPEUTICS, INC.
Datakwaliteit: 83%
ACTU
Nasdaq
Manufacturing
Chemicals
€ 1,86
▼
€ 0,07
(-3,39%)
Marktkapitalisatie: 43,99 M
Prijs
€ 1,86
Marktkapitalisatie
43,99 M
Dagbereik
€ 1,77 — € 1,94
52-Weeksbereik
€ 1,77 — € 11,99
Volume
77.585
Openen € 1,94
50D / 200D Gem.
€ 3,55
47,73% below
50D / 200D Gem.
€ 6,08
69,50% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -19,21 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-536,74%
Onder sectorgemiddelde (-53,41%)
ROIC-390,17%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio2,74
Interest Coverage-1110,88
Waardering
PE (TTM)
-1,98
Onder sectorgemiddelde (-1,48)
P/B Ratio4,02
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -2,0 | -1,5 |
| P/B | 4,0 | 1,6 |
| ROE % | -536,7 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -22,23 M |
| ROE | -536,74% | ROA | -180,11% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -19,21 M |
| ROIC | -390,17% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2,74 |
| Interest Coverage | -1110,88 | Asset Turnover | N/A |
| Working Capital | 11,07 M | Tangible Book Value | 10,94 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1,98 | Forward P/E | N/A |
| P/B Ratio | 4,02 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -43,67% | ||
| Market Cap | 43,99 M | Enterprise Value | 27,06 M |
| Per Share | |||
| EPS (Diluted TTM) | -1,06 | Revenue / Share | N/A |
| FCF / Share | -0,81 | OCF / Share | -0,81 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 86,41% |
| SBC-Adj. FCF | -23,95 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | — | — |
| Net Income | -22,23 M | -27,29 M |
| EPS (Diluted) | -1,06 | -3,26 |
| Gross Profit | — | — |
| Operating Income | -22,50 M | -25,16 M |
| EBITDA | — | — |
| R&D Expenses | 10,29 M | 18,68 M |
| SG&A Expenses | — | — |
| D&A | — | — |
| Interest Expense | 20.250,0 | 18.717,0 |
| Income Tax | 800,0 | 800,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 14,04 M | 9,32 M |
| Total Liabilities | 6,11 M | 9,21 M |
| Shareholders' Equity | 7,92 M | 104.186,0 |
| Total Debt | — | — |
| Cash & Equivalents | 13,16 M | 8,64 M |
| Current Assets | 13,64 M | 9,21 M |
| Current Liabilities | 5,71 M | 8,80 M |
{"event":"ticker_viewed","properties":{"ticker":"ACTU","listing_kind":"stock","pathname":"/stocks/actu","exchange":"Nasdaq","country":"US"}}